title: Central nervous system disorders after renal transplantation in cats.
abstract: OBJECTIVE
  This study describes the incidence and severity of postoperative central nervous system (pCNS) disorders in feline renal transplant recipients.
  
  
  METHODS
  A retrospective study based on the medical records of cats that received renal allografts from 1987 to 1996.
  
  
  METHODS
  Fifty-seven client-owned cats received renal allografts for the treatment of renal failure.
  
  
  METHODS
  The frequency, duration, severity, and treatment of episodes of pCNS disorders were recorded from the medical records.
  
  
  RESULTS
  Twelve (21%) of 57 cats had pCNS disorders 1 hour to 5 days after the surgical procedure. Seven cats survived; four had single or multiple seizure episodes, and two had seizure episodes or disorientation followed by a period of coma. One cat became temporarily ataxic and blind after restraint for venipuncture. Five cats died; all had episodes of disorientation or seizures, or both, that progressed to a nonrecoverable comatose state, respiratory arrest or cardiac arrest, or both. There were no significant differences between the two groups in preoperative serum creatinine, blood urea nitrogen, or cholesterol levels, and intraoperative blood pressure measurements. There were no significant differences in the postoperative serum glucose levels, electrolytes levels, or osmolality between the two groups. The cats with pCNS disorders had a mean preoperative trough cyclosporine A (CyA) whole blood level of 429 ng/mL; cats without pCNS disorders had a significantly (P = .0116) higher mean preoperative trough CyA whole blood level of 736 ng/mL.
  
  
  CONCLUSIONS
  Central nervous system disorders are a common and often fatal complication of renal transplantation in cats.
  
  
  CONCLUSIONS
  Recognition of pCNS disorders, and possible causes, will help develop hypotheses to investigate the problem.
authors.affiliation: Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis 95616-8745, USA.
authors.forename: C R
authors.initials: CR
authors.lastname: Gregory
authors.forename: K G
authors.initials: KG
authors.lastname: Mathews
authors.forename: L R
authors.initials: LR
authors.lastname: Aronson
authors.forename: J E
authors.initials: JE
authors.lastname: Ilkiw
authors.forename: R A
authors.initials: RA
authors.lastname: LeCouteur
authors.forename: J
authors.initials: J
authors.lastname: Aldrich
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D001806:Blood Urea Nitrogen; D002371:Cat Diseases / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D002415:Cats; D002493:Central Nervous System Diseases / Q000453:epidemiology / Q000209:etiology / Q000662:veterinary*; D002784:Cholesterol / Q000097:blood; D003128:Coma / Q000453:epidemiology / Q000209:etiology / Q000662:veterinary; D003401:Creatine / Q000097:blood; D005260:Female; D015994:Incidence; D016030:Kidney Transplantation / Q000009:adverse effects / Q000662:veterinary*; D008297:Male; D012189:Retrospective Studies; D012640:Seizures / Q000453:epidemiology / Q000209:etiology / Q000662:veterinary; D012720:Severity of Illness Index; D014184:Transplantation, Homologous / Q000009:adverse effects / Q000662:veterinary
chemical_list: D001786:Blood Glucose; D002784:Cholesterol; D003401:Creatine